Q3 2025 results spotlight AI-first pivot

Genpact (G) recently reported strong Q3 2025 results, putting its AI-focused shift and agentic operations in the spotlight and giving investors fresh data on how platforms like AI Maestro and key cloud partnerships are translating into business momentum.

The Q3 update comes after a mixed period for investors, with the share price at US$40.21 and a recent 7 day share price return of 7.11% contrasting with a weaker year to date share price return of a 12.42% decline and a 1 year total shareholder return of a 22.59% decline, suggesting recent momentum has picked up even though longer term investors are still sitting on losses.

If Genpact’s AI push has your attention, you might also want to see which other names are gaining traction in this space through our screener of 61 profitable AI stocks that aren't just burning cash.

With Genpact trading at US$40.21, currently at a discount to both certain intrinsic value estimates and analyst targets while following weak 1-year returns, is this an underappreciated AI operator or is the market already accounting for the next phase of growth?

Most Popular Narrative: 17.3% Undervalued

Genpact’s most followed narrative pegs fair value at $48.64 versus the last close at $40.21, so the gap between price and projected value is front and center.

The analysts have a consensus price target of $52.444 for Genpact based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $58.0, and the most bearish reporting a price target of just $47.0.

Want to see what sits under that fair value? The narrative focuses on revenue expansion, margin uplift and a future earnings multiple that remains below the broader industry. The key question is how those moving parts work together over several years to support the valuation gap.

Result: Fair Value of $48.64 (UNDERVALUED)

However, the story could change if legacy outsourcing slows faster than expected, or if heavy AI investment fails to translate into the higher margin work analysts model.

Next Steps

With all this in mind, do you feel the market is too cautious or just about right on Genpact? Take a moment to review the numbers, compare the narratives and risks, then check the positive side of the story through 5 key rewards.

Looking for more investment ideas?

If Genpact has sharpened your focus, do not stop here. Broaden your watchlist with other ideas that fit different goals, timeframes and risk levels.

• Target potential mispricing by scanning companies our tools flag as undervalued through 45 high quality undervalued stocks and see which ones deserve a closer look on your watchlist.
• Strengthen your income stream by reviewing companies in our list of 13 dividend fortresses and assess whether any align with your dividend goals.
• Prioritise resilience by reviewing our 76 resilient stocks with low risk scores and focus your research on businesses that score well on stability and risk controls.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.